Xcout IntelSign inSubscribe

Kamari Pharma competitors & alternatives

PharmaceuticalsIsrael

The 12 closest competitors and alternatives to Kamari Pharma among pharmaceuticals companies — ranked by similarity to what Kamari Pharma actually does, not by market-cap band.

12Competitors listed

Subscribe to see Kamari Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Kamari Pharma

Kamari Pharma (now Orvida Pharma) is a privately held biopharmaceutical company located at the Weizmann Science Park in Ness Ziona, Israel, focused on developing therapeutic treatments.

Kamari Pharma at a glance

Kamari Pharma is a pharmaceuticals company headquartered in Israel. Its most recent funding round, Series A, raised $23M in June 2025. Xcout tracks 10 named people at Kamari Pharma, including David Aviezer (CEO).

Kamari Pharma leadership

  • David AviezerCEO
  • Asaf YarkoniChief Finance Officer
  • Einat Brill AlmonChief Regulatory Officer
  • Liora BraimanChief Scientific Officer
  • Dayana MichelSVP Medical & Clinical Affairs
  • Myriam GolemboSVP Regulatory and Strategy Affairs

4 more named people on record for Kamari Pharma, with roles, board committees and tenure — see the full roster →

Kamari Pharma funding rounds

Every round on record:

DateRoundAmountInvestors
Series A$23M10 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Kamari Pharma competitors

Ranked by semantic similarity — how close each company is to Kamari Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

KamadaKMDA · Biotech, PharmaceuticalsRehovot, Israel
68% matchPublic

Biotech, Pharmaceuticals

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.

Market cap$404.9M
Employees420
Kamada competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Kamari Pharma and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kamari Pharmaand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →